Macrophage colony-stimulating factor gene transduction into human lung cancer cells differentially regulates metastasis formations in various organ microenvironments of natural killer cell-depleted SCID mice

Cancer Research

Volumn 57, Issue 4, 1997, Pages 784-790

  Yano, Seiji ^a   Nishioka, Yasuhiko ^a   Nokihara, Hiroshi ^a   Sone, Saburo ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

COLONY STIMULATING FACTOR 1;

ANIMAL CELL; ARTICLE; CANCER CELL; CELL DIFFERENTIATION; GENETIC HETEROGENEITY; GENETIC TRANSDUCTION; HOST RESISTANCE; HUMAN; HUMAN CELL; KILLER CELL; LIVER METASTASIS; LUNG CANCER; LYMPH NODE METASTASIS; MOLECULAR INTERACTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SCID MOUSE; TUMOR GROWTH;

ANIMALS; ANTIBODIES, MONOCLONAL; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SMALL CELL; HUMANS; KIDNEY NEOPLASMS; KILLER CELLS, NATURAL; LIVER NEOPLASMS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MACROPHAGE COLONY-STIMULATING FACTOR; MICE; MICE, SCID; NEOPLASM INVASIVENESS; TRANSFECTION;

EID: 0031050397     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Fidler, I. J. Critical factors in the biology of human cancer metastasis: twenty-eighth G. H. A. Clowes Memorial Award Lecture. Cancer Res., 50: 6130-6138, 1990.
2. Nicolson, G. Cancer progression and growth: relationship of paracrine and autocrine growth mechanisms to organ preference of metastasis. Exp. Cell Res., 204: 171-180, 1993.
3. Fidler, I. J. Orthotopic implantation of human colon carcinomas into nude mice provides a valuable model for biology and therapy of cancer metastasis. Cancer Metastasis Rev., 10: 229-243, 1990.
4. Yano, S., Nishioka, Y., Izumi, K., Tsuruo, T., Tanaka, T., Miyasaka, M., and Sone, S. Novel metastasis model of human lung cancer in SCID mice depleted of NK cells. Int. J. Cancer, 67: 212-218, 1996.
5. Walsh, P., Dorner, A., Duke, R. C., Su, L-J., and Glode, L. M. Macrophage colony-stimulating factor complementary DNA: a candidate for gene therapy in metastatic melanoma. J. Natl. Cancer Inst., 87: 809-816, 1995.
6. Kuo, T. H., Kubota, T., Watanabe, M., Furukawa, T., Kase, S., Tanino, H., Nishibori, H., Saikawa, Y., Teramoto, T., Ishibiki, K., Kitajima, M., and Hoffman, R. Orthotopic reconstitution of human small cell lung carcinoma after intravenous transplantation in SOID mice. Anticancer Res., 12: 1407-1410, 1992.
7. Mantovani, A., Bottazzi, B., Colotta, F., Sozzani, S., and Ruco, L. The origin and function of tumor-associated macrophages. Immunol. Today, 13: 265-270, 1992.
8. Heike, Y., Sone, S., Yano, S., Seimiya, H., Tsuruo, T., and Ogura, T. M-CSF gene transduction in multidrug-resistant human cancer cells to enhance anti-P-glycoprotein antibody-dependent macrophage-mediated cytotoxicity. Int. J. Cancer, 54; 851-857, 1993.
9. Kawasaki, E. S., Ladner, M. B., Wang, A. M., Van Arsdell, J., Warren, M. K., Coyne, M. Y., Schweickart, V. L., Lee, M., Wilson, K. J., Boosman, A., Stanley, E. R., Ralph, P., and Mark, D. F. Molecular cloning of a complementary DNA encoding human macrophage-specific colony-stimulating factor (CSF-1). Science (Washington DC), 230: 290-296, 1985.
10. Sieff, C. A. Hematopoietic growth factors. J. Clin. Invest., 79: 1549-1559, 1988.
11. Wang, J. M., Griffin, J. D., Rambaldi, A., Chen, Z. G., and Mantovani, A. Induction of monocyte migration by recombinant macrophage colony-stimulating factor. J. Immunol., 141: 575-579, 1988.
12. Warren, M. K., and Ralph, P. Macrophage growth factor CSF-1 stimulates human monocyte production of interferon, tumor necrosis factor, and colony-stimulating activity. J. Immunol., 137: 2281-2285, 1986.
13. Sampson-Johannes, A., and Carlino, J. A. Enhancement of human monocyte tumoricidal activity by recombinant M-CSF. J. Immunol., 141: 3680-3686, 1988.
14. Munn, D. H., and Cheung, N. K. V. Antibody-dependent antitumor-immunity cytotoxicity by human monocytes cultured with recombinant macrophage colony-stimulating factor. Induction of efficient antibody-mediated antitumor cytotoxicity not detected by isotope release assay. J. Exp. Med., 170: 511-521, 1989.
15. Muffson, R. A., Aghajanian, J., Wong, G., Woodhouse, C., and Morgan, A. C. Macrophage colony-stimulating factor enhances monocyte and macrophage antibodydependent cell-mediated cytotoxicity. Cell. Immunol., 119: 182-192, 1989.
16. Hume, D. A., Donahue, R. E., and Fidler, I. J. The therapeutic effect of human recombinant macrophage colony-stimulating factor (CSF-1) in experimental murine metastatic melanoma. Lymphokine Res., 8: 69-77, 1989.
17. Lu, L., Shen, R-N., Lin, Z-H., Aukerman, S. L., Ralph, P., and Broxmeyer, H. E. Aniiiumor effects of recombinant human macrophage colony-stimulating factor, alone or in combination with local irradiation in mice inoculated with Lewis lung carcinoma cells. Int. J. Cancer, 47: 143-147, 1991.
18. Lu, L., Xiao, M., Wu, B., Wang, W. X., Van, W. R., Broxmeyer, H. E., and Shen, R-N. In vivo effects of purified recombinant human macrophage colony- stimulating factor with local hyperthermia on tumor progression in B16a melanoma-bearing mice. Int. J. Hematol., 58: 139-152, 1993.
19. Hamada, H., and Tsuruo, T. Functional role for the 170- to 180-kDa glycoprotein specific to drug-resistant tumor cells as revealed by monoclonal antibodies. Proc. Natl. Acad. Sci. USA, 83: 7785-7789, 1986.
20. Tanaka T., Tsudo, M., Karasuyama, H., Kitamura, F., Kono, T., Hatakeyama, M., Tanigushi, T., and Miyasaka, M. A novel monoclonal antibody against murine IL-2 receptor β-chain: characterization of receptor expression in normal lymphoid cells and EL-4 cells. J. Immunol., 147: 2222-2228, 1991.
21. Kyoizumi, S., Akiyama, M., Kouno, N., Kobuke, K., Hakoda, M., Jones, S. L., and Yamakido, M. Monoclonal antibodies to human squamous cell carcinoma of the lung and their application to tumor diagnosis. Cancer Res., 45: 3274-3281, 1985.
22. Minato, K., Kanazawa, F., Nishio, K., Nakagawa, K., Fujisawa, Y., and Saijo, N. Characterization of an etoposide-resistant human small cell lung cancer cell line. Cancer Chemother, Pharmacol., 26: 313-317, 1990.
23. Takahashi, M., Hirato, T., Takano, M., Nishida, T., Nagamura, K., Kamogashira, T., Nakai, S., and Hirai, Y. Amino-terminal region of human macrophage colony-stimulating factor (M-CSF) is sufficient for its in vitro biological activity: molecular cloning and expression of carboxyl-terminal-deletion mutants of human M-CSR Biochem. Biophys. Res. Commun., 167: 892-901, 1989.
24. Yano, S., Yanagawa, H., Nishioka, Y., Mukaida, N., Matsushima, K., and Sone, S. T helper 2 cytokines differently regulate monocyte chemoattractant protein-1 (MCP-1) production by human peripheral blood monocytes and alveolar macrophages. J. Immunol., 157: 2660-2665, 1996.
25. Sone, S., Nakanishi, M., Ohmoto, Y., Yanagawa, H., and Ogura, T. Macrophage colony-stimulating factor activity in malignant pleural effusions and its augmentation by intrapleural interleukin-2 infusions. Chest, 99: 377-381, 1991.
26. Green L. M., Reade, J. L., and Ware, C. F. Rapid colorimetric assay for cell viability: application to the quantitation of cytotoxic and growth-inhibitory lymphokines. J. Immunol. Methods, 70: 257-268, 1984.
27. Yano, S., Sone, S., Nishioka, Y., Naito, M., Tsunio, T., and Ogura, T. Cyclosporin A enhances susceptibility of multidrug-resislant human cancer cells to anti-P-glycoprotein antibody-dependent cytotoxicity of monocytes, but not of lymphocytes. Jpn. J. Cancer Res., 85: 194-203, 1994.
28. 125I]5-iodo-2′-deoxyuridme. J.4 Natl. Cancer Inst., 45: 773-782, 1970.
29. Bruckner, A., Filderman, A. E., Kirchheimer, J. C., Binder, B. R., and Remold H. G. Endogenous receptor-bound urokinase mediates tissue invasion of the human lung carcinoma cell lines A549 and Calu-1. Cancer Res., 52: 3043-3047, 1992.
30. Filderman, A. E., Bruckner, A., Kacinski, B. M., Deng, N., and Remold, H. G. Macrophage colony-stimulating factor (CSF-1) enhances invasiveness in CSF-1 receptor-positive carcinoma cell lines. Cancer Res., 52: 3661-3666, 1992.
31. Fidler, I. J. Selection of successive tumor lines for metastasis. Nat. New Biol., 242: 148-149, 1973.
32. Morikawa, K., Walker, S. M., Jessup, J. M., and Fidler, I. J. In vivo selection of highly metastatic cells from surgical specimens of different primary human colon carcinoma implanted into nude mice. Cancer Res., 48: 1943-1948, 1988.
33. Bosma, G. C., Custer, R. P., and Bosma, M. J. A severe combined immunodeficiency mutation in the mouse. Nature (Lond.), 301: 527-530, 1983.
34. Fidler, I. J., and Ellis, L. M. The implications of angiogenesis for the biology and therapy of cancer metastasis. Cell, 79: 185-188, 1994.
35. Chambers, S. K., Wang, Y., Gertz, R. E., and Kacinski, B. M. Macrophage colonystimulating factor mediates invasion of ovarian cancer cells through urokinase. Cancer Res., 55: 1578-1585, 1995.
36. Curley, S. A., Roh, M. S., Kleinerman, E., and Klostergaard, J. Human recombinant macrophage colony-stimulating factor activates murine Kupffer cells to a cytotoxic state. Lymphokine Res., 9: 355-363, 1990.
37. De Nichilo, M. O., and Burns, G. F. Macrophage colony- stimulating factor induces thrombospondin 1 production by cultured human macrophages. J. Cell. Physiol., 164: 223-231, 1995.
38. Zabrenetzky, V., Harris, C. C., Steeg, P. S., and Roberts, D. D. Expression of the extracellular matrix molecule thrombospondin inversely correlates with malignant progression in melanoma, lung, and breast carcinoma cell lines. Int. J. Cancer, 59: 191-195, 1994.
39. Hughes, D. A., Fraser, I. P., and Gordon, S. Murine macrophage scavenger receptor in vivo expression and function as receptor for macrophage adhesion in lymphoid and non-lymphoid organs. Eur. J. Immunol., 25: 466-473, 1995.